News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
182 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17565)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (164)
2 (27)
3 (38)
4 (284)
5 (268)
6 (206)
7 (197)
8 (98)
9 (4)
10 (7)
11 (190)
12 (219)
13 (201)
14 (199)
15 (83)
16 (9)
17 (6)
18 (182)
19 (259)
20 (94)
21 (65)
22 (40)
23 (1)
24 (3)
25 (64)
26 (61)
27 (54)
28 (44)
29 (94)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
BioCapital
Essential Medical Announces IDE Study Results to be Presented in Late Breaking Clinical Science Session at TVT 2018
The MANTA™ system, with resorbable collagen material, successfully demonstrates fast, reliable and biological large bore vascular closure with rapid hemostasis
June 18, 2018
·
3 min read
Leviticus Cardio Announces Successful Animal Trial Demonstrating Wireless Power to Jarvik 2000
Leviticus Cardio announces the successful animal implantation of the world’s first Hybrid Wireless Fully Implanted Ventricular Assisted System or “Hybrid FILVAS.”
June 18, 2018
·
3 min read
Drug Development
Array BioPharma to Present Overall Survival Results from the Phase 3 BEACON CRC Safety Lead-In in BRAF-Mutant Colorectal Cancer at the ESMO 20th World Congress on Gastrointestinal Cancer
Encore investor webcast presentation June 23, 2018
June 18, 2018
·
8 min read
Genetown
Haemonetics Completes Debt Refinancing With Five-Year Senior Unsecured Credit Facilities
Haemonetics Corporation announced that the Company has entered into a new $700 million credit agreement with its lenders
June 18, 2018
·
3 min read
BioForest
DIA Launches DIA NOW for On-Demand Global Knowledge Access
DIA announced the launch of its newest product offering, DIA NOW.
June 18, 2018
·
3 min read
Drug Development
Avedro Announces Enrollment of First Patient in U.S. Pivotal Phase 3 Epi-on Corneal Cross-Linking Trial for Progressive Keratoconus
Clinical Study to Support Application for FDA Approval for Epi-on Corneal Cross-Linking Procedure with New Drug Formulation and Use of Oxygen.
June 18, 2018
·
3 min read
Pharm Country
Blue Earth Diagnostics Announces Fluciclovine F 18 Research Presentations at Upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
Blue Earth Diagnostics today announced that presentations related to the clinical use of fluciclovine F 18 injection will be occurring at the SNMMI Annual Meeting
June 18, 2018
·
4 min read
FDA
PerkinElmer’s EUROIMMUN Receives 510(k) Clearance for Crithidia luciliae and Crithidia luciliae Sensitive Diagnostic Tests
Testing Performed Together with EUROPattern System Can Help Accelerate Lupus Diagnosis
June 18, 2018
·
3 min read
FDA
FDA Approves the Next Generation of Customized LASIK Treatment with iDESIGN Refractive Studio
Johnson & Johnson Vision announced today the U.S. Food and Drug Administration (FDA) approval of the iDESIGN Refractive Studio
June 18, 2018
·
5 min read
Hebron Technology Co., Ltd. Exhibited at ACHEMA
Hebron Technology Co., Ltd. announced its participation in the ACHEMA Frankfurt 2018 International Exhibition-Congress (“ACHEMA”)
June 18, 2018
·
3 min read
Previous
6 of 19
Next